Literature DB >> 17015816

Phenomenology of children and adolescents with bipolar spectrum disorders.

David Axelson1, Boris Birmaher, Michael Strober, Mary Kay Gill, Sylvia Valeri, Laurel Chiappetta, Neal Ryan, Henrietta Leonard, Jeffrey Hunt, Satish Iyengar, Jeffrey Bridge, Martin Keller.   

Abstract

CONTEXT: Children and adolescents who present with manic symptoms frequently do not meet the full DSM-IV criteria for bipolar I disorder (BP-I).
OBJECTIVE: To assess the clinical presentation and family history of children and adolescents with BP-I, bipolar II disorder (BP-II), and bipolar disorder not otherwise specified (BP-NOS).
DESIGN: Subjects and their primary caretaker were assessed by semistructured interview, and family psychiatric history was obtained from interview of the primary caretaker.
SETTING: Outpatient and inpatient units at 3 university centers. PARTICIPANTS: A total of 438 children and adolescents (mean +/- SD age, 12.7 +/- 3.2 years) with BP-I (n = 255), BP-II (n = 30), or BP-NOS (n = 153). MAIN OUTCOME MEASURES: Lifetime psychiatric history and family history of psychiatric disorders.
RESULTS: Youth with BP-NOS were not diagnosed as having BP-I primarily because they did not meet the DSM-IV duration criteria for a manic or mixed episode. There were no significant differences among the BP-I and BP-NOS groups in age of onset, duration of illness, lifetime rates of comorbid diagnoses, suicidal ideation and major depression, family history, and the types of manic symptoms that were present during the most serious lifetime episode. Compared with youth with BP-NOS, subjects with BP-I had more severe manic symptoms, greater overall functional impairment, and higher rates of hospitalization, psychosis, and suicide attempts. Elevated mood was present in 81.9% of subjects with BP-NOS and 91.8% of subjects with BP-I. Subjects with BP-II had higher rates of comorbid anxiety disorders compared with the other 2 groups and had less functional impairment and lower rates of psychiatric hospitalization than the subjects with BP-I.
CONCLUSIONS: Children and adolescents with BP-II and BP-NOS have a phenotype that is on a continuum with that of youth with BP-I. Elevated mood is a common feature of youth with BP-spectrum illness.

Entities:  

Mesh:

Year:  2006        PMID: 17015816     DOI: 10.1001/archpsyc.63.10.1139

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  210 in total

1.  Parents' perceptions of benefit of children's mental health treatment and continued use of services.

Authors:  Sarah Horwitz; Christine Demeter; Margaret Hayden; Amy Storfer-Isser; Thomas W Frazier; Mary A Fristad; L Eugene Arnold; Eric A Youngstrom; Boris Birmaher; David Axelson; Robert L Findling
Journal:  Psychiatr Serv       Date:  2012-08       Impact factor: 3.084

2.  Neural correlates of cognitive flexibility in children at risk for bipolar disorder.

Authors:  Pilyoung Kim; Sarah E Jenkins; Megan E Connolly; Christen M Deveney; Stephen J Fromm; Melissa A Brotman; Eric E Nelson; Daniel S Pine; Ellen Leibenluft
Journal:  J Psychiatr Res       Date:  2011-10-22       Impact factor: 4.791

3.  Are obstetrical, perinatal, and infantile difficulties associated with pediatric bipolar disorder?

Authors:  Marykate Martelon; Timothy E Wilens; Jesse P Anderson; Nicholas R Morrison; Janet Wozniak
Journal:  Bipolar Disord       Date:  2012-05-29       Impact factor: 6.744

4.  Anxiety disorders and rapid cycling: data from a cohort of 8129 youths with bipolar disorder.

Authors:  Ruby Castilla-Puentes; Regina Sala; Bernardo Ng; Juan Galvez; Alvaro Camacho
Journal:  J Nerv Ment Dis       Date:  2013-12       Impact factor: 2.254

5.  Assessment of personality dimensions in children and adolescents with bipolar disorder using the Junior Temperament and Character Inventory.

Authors:  Rene L Olvera; Manoela Fonseca; Sheila C Caetano; John P Hatch; Kristina Hunter; Mark Nicoletti; Steven R Pliszka; C Robert Cloninger; Jair C Soares
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

6.  The Child Behavior Checklist (CBCL) and the CBCL-bipolar phenotype are not useful in diagnosing pediatric bipolar disorder.

Authors:  Rasim Somer Diler; Boris Birmaher; David Axelson; Ben Goldstein; MaryKay Gill; Michael Strober; David J Kolko; Tina R Goldstein; Jeffrey Hunt; Mei Yang; Neal D Ryan; Satish Iyengar; Ronald E Dahl; Lorah D Dorn; Martin B Keller
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

7.  Family-focused treatment for adolescents with bipolar disorder.

Authors:  David J Miklowitz; Elizabeth L George; David A Axelson; Eunice Y Kim; Boris Birmaher; Christopher Schneck; Carol Beresford; W Edward Craighead; David A Brent
Journal:  J Affect Disord       Date:  2004-10       Impact factor: 4.839

8.  Amygdala-prefrontal cortical functional connectivity during implicit emotion processing differentiates youth with bipolar spectrum from youth with externalizing disorders.

Authors:  Danella Hafeman; Genna Bebko; Michele A Bertocci; Jay C Fournier; Henry W Chase; Lisa Bonar; Susan B Perlman; Michael Travis; Mary Kay Gill; Vaibhav A Diwadkar; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; L Eugene Arnold; Mary A Fristad; Thomas W Frazier; Eric A Youngstrom; Robert L Findling; Mary L Phillips
Journal:  J Affect Disord       Date:  2016-10-11       Impact factor: 4.839

9.  Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder.

Authors:  Timothy E Wilens; Joseph Biederman; MaryKate Martelon; Courtney Zulauf; Jesse P Anderson; Nicholas W Carrellas; Amy Yule; Janet Wozniak; Ronna Fried; Stephen V Faraone
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

10.  The morbidity of subthreshold pediatric bipolar disorder: A systematic literature review and meta-analysis.

Authors:  Carrie A H Vaudreuil; Stephen V Faraone; Maura Di Salvo; Janet R Wozniak; Rebecca A Wolenski; Nicholas W Carrellas; Joseph Biederman
Journal:  Bipolar Disord       Date:  2018-12-19       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.